{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:36:25Z","timestamp":1760574985543,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Construction Fund of Key Medical Disciplines of Hangzhou - Rare Disease","award":["2025HZZD09"],"award-info":[{"award-number":["2025HZZD09"]}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project","award":["2025KY1187"],"award-info":[{"award-number":["2025KY1187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00415-025-13361-0","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T06:14:56Z","timestamp":1757830496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the predictive potential of Th1 (IFN-\u03b3+CD4+)\/CD4+ in rapidly progressive amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2117-9183","authenticated-orcid":false,"given":"Jiahui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuechen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4816-5907","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"13361_CR1","doi-asserted-by":"publisher","unstructured":"El F, Sa G, SP et al (2022) Amyotrophic lateral sclerosis. Lancet Lond Engl 400. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"13361_CR2","unstructured":"Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31797084\/. Accessed 2 Mar 2025"},{"key":"13361_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075037","volume":"383","author":"H Ilieva","year":"2023","unstructured":"Ilieva H, Vullaganti M, Kwan J (2023) Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ 383:e075037. https:\/\/doi.org\/10.1136\/bmj-2023-075037","journal-title":"BMJ"},{"key":"13361_CR4","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B et al (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88:2302\u20132309. https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"key":"13361_CR5","unstructured":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32799899\/. Accessed 2 Apr 2025"},{"key":"13361_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/21678421.2019.1572192","volume":"20","author":"D Lanznaster","year":"2019","unstructured":"Lanznaster D, Bejan-Angoulvant T, Patin F et al (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener 20:199\u2013206. https:\/\/doi.org\/10.1080\/21678421.2019.1572192","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"13361_CR7","unstructured":"Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/35614165\/. Accessed 2 Apr 2025"},{"key":"13361_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","volume":"74","author":"C Lunetta","year":"2017","unstructured":"Lunetta C, Lizio A, Maestri E et al (2017) Serum C-reactive protein as a prognostic biomarker in Amyotrophic Lateral Sclerosis. JAMA Neurol 74:660\u2013667. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6179","journal-title":"JAMA Neurol"},{"key":"13361_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00515-1","volume":"17","author":"KA Staats","year":"2022","unstructured":"Staats KA, Borchelt DR, Tansey MG, Wymer J (2022) Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegener 17:11. https:\/\/doi.org\/10.1186\/s13024-022-00515-1","journal-title":"Mol Neurodegener"},{"key":"13361_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000953","volume":"8","author":"BJ Murdock","year":"2021","unstructured":"Murdock BJ, Goutman SA, Boss J et al (2021) Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol Neuroimmunol Neuroinflamm 8:e953. https:\/\/doi.org\/10.1212\/NXI.0000000000000953","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13361_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12974-024-03327-w","volume":"21","author":"T Itou","year":"2024","unstructured":"Itou T, Fujita K, Okuzono Y et al (2024) Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study. J Neuroinflammation 21:331. https:\/\/doi.org\/10.1186\/s12974-024-03327-w","journal-title":"J Neuroinflammation"},{"key":"13361_CR12","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani S, Seitz C, Cui C et al (2022) T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun 13:6733. https:\/\/doi.org\/10.1038\/s41467-022-34526-9","journal-title":"Nat Commun"},{"key":"13361_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41593-023-01323-6","volume":"26","author":"F Berriat","year":"2023","unstructured":"Berriat F, Lobsiger CS, Boill\u00e9e S (2023) The contribution of the peripheral immune system to neurodegeneration. Nat Neurosci 26:942\u2013954. https:\/\/doi.org\/10.1038\/s41593-023-01323-6","journal-title":"Nat Neurosci"},{"key":"13361_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201. https:\/\/doi.org\/10.1186\/s12974-014-0201-8","journal-title":"J Neuroinflammation"},{"key":"13361_CR15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005","journal-title":"Clin Neurophysiol"},{"key":"13361_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200241","volume":"11","author":"BJ Murdock","year":"2024","unstructured":"Murdock BJ, Zhao B, Pawlowski KD et al (2024) Peripheral immune profiles predict ALS progression in an age- and sex-dependent manner. Neurol Neuroimmunol Neuroinflamm 11:e200241. https:\/\/doi.org\/10.1212\/NXI.0000000000200241","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13361_CR17","unstructured":"Lundberg S, Lee S-I (2017) A unified approach to interpreting model predictions"},{"key":"13361_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18:211\u2013220. https:\/\/doi.org\/10.1016\/S1474-4422(18)30394-6","journal-title":"Lancet Neurol"},{"key":"13361_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncel.2014.00021","volume":"8","author":"S Garbuzova-Davis","year":"2014","unstructured":"Garbuzova-Davis S, Sanberg PR (2014) Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci 8:21. https:\/\/doi.org\/10.3389\/fncel.2014.00021","journal-title":"Front Cell Neurosci"},{"key":"13361_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1113\/JP270213","volume":"595","author":"D Arbour","year":"2017","unstructured":"Arbour D, Vande Velde C, Robitaille R (2017) New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol 595:647\u2013661. https:\/\/doi.org\/10.1113\/JP270213","journal-title":"J Physiol"},{"key":"13361_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0271-7","volume":"13","author":"G Nardo","year":"2018","unstructured":"Nardo G, Trolese MC, Verderio M et al (2018) Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol Neurodegener 13:42. https:\/\/doi.org\/10.1186\/s13024-018-0271-7","journal-title":"Mol Neurodegener"},{"key":"13361_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.657465","volume":"15","author":"Y Xie","year":"2021","unstructured":"Xie Y, Luo X, He H, Tang M (2021) Novel insight into the role of immune dysregulation in amyotrophic lateral sclerosis based on bioinformatic analysis. Front Neurosci 15:657465. https:\/\/doi.org\/10.3389\/fnins.2021.657465","journal-title":"Front Neurosci"},{"key":"13361_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells13090749","volume":"13","author":"Y Gao","year":"2024","unstructured":"Gao Y, Lu Y, Liang X et al (2024) CD4+ t-cell senescence in neurodegenerative disease: pathogenesis and potential therapeutic targets. Cells 13:749. https:\/\/doi.org\/10.3390\/cells13090749","journal-title":"Cells"},{"key":"13361_CR24","unstructured":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/18809917\/. Accessed 23 Apr 2025"},{"key":"13361_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1277399","volume":"17","author":"S Mimic","year":"2023","unstructured":"Mimic S, Aru B, Pehlivano\u011flu C et al (2023) Immunology of amyotrophic lateral sclerosis\u2014role of the innate and adaptive immunity. Front Neurosci 17:1277399. https:\/\/doi.org\/10.3389\/fnins.2023.1277399","journal-title":"Front Neurosci"},{"key":"13361_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Beers DR, Appel SH (2013) Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 8:888\u2013899. https:\/\/doi.org\/10.1007\/s11481-013-9489-x","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"13361_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13238-017-0369-7","volume":"8","author":"C Zhong","year":"2017","unstructured":"Zhong C, Zhu J (2017) Transcriptional regulators dictate innate lymphoid cell fates. Protein Cell 8:242\u2013254. https:\/\/doi.org\/10.1007\/s13238-017-0369-7","journal-title":"Protein Cell"},{"key":"13361_CR28","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","volume":"10","author":"M Jin","year":"2020","unstructured":"Jin M, G\u00fcnther R, Akg\u00fcn K et al (2020) Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep 10:5941. https:\/\/doi.org\/10.1038\/s41598-020-62756-8","journal-title":"Sci Rep"},{"key":"13361_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie H, Zheng Y, Li R et al (2013) Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat Med 19:322\u2013328. https:\/\/doi.org\/10.1038\/nm.3085","journal-title":"Nat Med"},{"key":"13361_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"C-H Lu","year":"2016","unstructured":"Lu C-H, Allen K, Oei F et al (2016) Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e244. https:\/\/doi.org\/10.1212\/NXI.0000000000000244","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13361_CR31","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00415-021-10508-7","volume":"268","author":"L Xu","year":"2021","unstructured":"Xu L, He B, Zhang Y et al (2021) Prognostic models for amyotrophic lateral sclerosis: a systematic review. J Neurol 268:3361\u20133370. https:\/\/doi.org\/10.1007\/s00415-021-10508-7","journal-title":"J Neurol"},{"key":"13361_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"H-J Westeneng","year":"2018","unstructured":"Westeneng H-J, Debray TPA, Visser AE et al (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","journal-title":"Lancet Neurol"},{"key":"13361_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M et al (2000) El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293\u2013299. https:\/\/doi.org\/10.1080\/146608200300079536","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"13361_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00415-020-10181-2","volume":"268","author":"V Grollemund","year":"2021","unstructured":"Grollemund V, Le Chat G, Secchi-Buhour M-S et al (2021) Manifold learning for amyotrophic lateral sclerosis functional loss assessment: development and validation of a prognosis model. J Neurol 268:825\u2013850. https:\/\/doi.org\/10.1007\/s00415-020-10181-2","journal-title":"J Neurol"},{"key":"13361_CR35","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/ene.14409","volume":"27","author":"J Sun","year":"2020","unstructured":"Sun J, Carrero JJ, Zagai U et al (2020) Blood biomarkers and prognosis of amyotrophic lateral sclerosis. Eur J Neurol 27:2125\u20132133. https:\/\/doi.org\/10.1111\/ene.14409","journal-title":"Eur J Neurol"},{"key":"13361_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.940375","volume":"13","author":"N Hertel","year":"2022","unstructured":"Hertel N, Kuzma-Kozakiewicz M, Gromicho M et al (2022) Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression-a multicenter study. Front Neurol 13:940375. https:\/\/doi.org\/10.3389\/fneur.2022.940375","journal-title":"Front Neurol"},{"key":"13361_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi P, Ferrante RJ, Matthews RT et al (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347\u2013350. https:\/\/doi.org\/10.1038\/6568","journal-title":"Nat Med"},{"key":"13361_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116496","author":"Y Wei","year":"2024","unstructured":"Wei Y, Zhong S, Yang H et al (2024) Current therapy in amyotrophic lateral sclerosis (ALS): a review on past and future therapeutic strategies. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116496","journal-title":"Eur J Med Chem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13361-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:30Z","timestamp":1760524530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13361-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13361"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13361-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest or relevant personal relationships that could have affected the integrity of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Hangzhou First People\u2019s Hospital (IIT-20230202\u20130016-01, IIT-2024460\u201301). The patient information was anonymized to protect privacy. This study is followed in accordance with the Ministry of Public Health of China Ethical Review Measures for biomedical research involving human subjects (Trial Vision 2007), and adhered to the ethical principles set forth in the 1964 Declaration of Helsinki and its subsequent revisions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients and their legal representatives provided informed consent prior to enrollment in the study and supplied accurate and truthful medical information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"631"}}